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Abstract
Background: Chronic kidney disease (CKD) is considered a serious public health problem, both in Brazil and worldwide,
with an increasing number of cases observed inrecent years. Especially, CKD has been reported to be highly prevalent in
those of African descent. However, Brazil lacks data from early-stage CKD population studies, and the prevalence of CKD is
unknown for both the overall and African descent populations. Hence, the present study aimsto estimate the prevalence
of early-stage CKD and its associated risk factors in African-Brazilians from isolated African-descent communities. Herein,
the detailed methodology design of the study is described.
Methods: This population-based, prospective, longitudinal, cohort study (PREVRENAL) is performed in three stages: first,
clinical, nutritional, and anthropometric evaluations; measurements of serum and urinary markers; and examinations of
comorbiditieswere performed. Second, repeated examinations of individuals with CKD, systemic arterial hypertension,
and/or diabetes mellitus; image screening; and cardiac risk assessment were performed. Third, long-term monitoring of
all selected individuals will be conducted (ongoing). Using probability sampling, 1539 individuals from 32 communities
were selected. CKD was defined asaglomerular filtration rate (GFR) ≤60 mL/min/1.73m2 and albuminuria > 30 mg/day.
Discussion: This study proposes to identify and monitor individuals with and without reduced GFR and high albuminuria
in isolated populations of African descendants in Brazil. As there are currently no specific recommendations for detecting
CKD in African descendants, four equations for estimating the GFR based on serum creatinine and cystatin C were used
and will be retrospectively compared. The present report describes the characteristics of the target population, selection
of individuals, and detection of a population at risk, along with the imaging, clinical, and laboratory methodologies used.
The first and second stages have been concluded and the results will be published in the near future. The subsequent
(third) stage is the long-term, continuous monitoring of individuals diagnosed with renal abnormalities or with CKD risk
factors. The entire study population will be re-evaluated five years after the study initiation. The expectation is to obtain
information about CKD evolution among this population, including the progression rate, complication development, and
cardiovascular events.
Keywords: African, Kidney disease, Glomerular filtration rate, Brazil, Population study
* Correspondence: natalinosalgadofilho@uol.com.br
1Kidney Disease Prevention Centre and Department of Medicine I, Federal
University of Maranhão, São Luís, MA, Brasil
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Salgado-Filho et al. BMC Nephrology  (2018) 19:43 
https://doi.org/10.1186/s12882-018-0839-z
Background
The clinical problem
Chronic kidney disease (CKD) is considered a serious
public health problem in Brazil and worldwide, with an in-
creasing number of cases during recent years [1, 2]. Brazil
still lacks data from population studies concerning early
stage CKD. The available information is restricted to those
from patients with stage 5 CKD, who received renal
replacement therapy in dialysis units [3, 4]. Approximately
40% of the Brazilian population is of African descent,
which ranks Brazil as the county with the second highest
percentage of African descendants worldwide (following
Nigeria). From a social-economic perspective, African
descendants are poorer and less educated when compared
with the overall population. Studies of this population
group in other countries, primarily the United States,
suggest that kidney diseases are more prevalent in those
of African descent, especially CKD, when compared with
other ethnic groups [5–8]. Ethnic studies also demon-
strated high rates of adverse cardiovascular events [9, 10],
diabetes mellitus (DM), and obesity, among other risk fac-
tors [11, 12], among this group. It is worth emphasizing
that even during the early stages of CKD,with discrete
decreases in glomerular filtration rate (GFR), cardiovascu-
lar diseases (CVD) are the primary causes of death [13].
Aims of this study
The present study (PREVRENAL) aimedto estimate the
prevalence of earlystage CKD and its associated risk fac-
tors in African Brazilians from isolated quilombo commu-
nities. It also aims to evaluate demographic, clinical, and
laboratory aspects of this patient population, and identify
factors associated with the development of CVD.
Methods and study design
Study location and population
This study was performed in Alcântara, Brazil, a city
located on the west coast of the State of Maranhão
(Northeastern Brazilian region). This city has 21,851
inhabitants, with 15,452 individuals (70.71%) from rural
populations distributed among 139 isolated African-
descent communities (quilombos). Ancestors of the eval-
uated ethnic group were from the Ivory Coast, Angola,
and Mozambique. Criteria used for ethnicity definition
was the same as that used by the Brazilian Geography
and Statistics Institute, which adopts self-assignment,
posteriorly confirmed by genetic examination.
The sample individuals of this study were selected
through probability sampling, which was designed in three
stages. First, there was a randomized selection of census
sectors, with probabilities proportional to population sizes.
Second, households were randomly selected. Third, individ-
uals aged over 18 years old, who lived in the selected house-
holds, were included in the study sample. Total sample size
was estimated per 15% CKD prevalence expectation, with
2% sampling error, and 95% confidence level, composing a
minimal sample of 1224 individuals. Finally, 1539 individ-
uals were selected from 32 quilombo communities. The
following were excluded from the sample: individuals under
18 years old, pregnant women, and patients with chronic
consumptive disease, hematological diseases, autoimmune
diseases, infections, chronic or acute kidney diseases under-
going dialysis treatment, thyroid disease, and those using
immunosuppressant drugs, based on clinical history and
physical examination.
Study design and summary
This was a cohort study with the following characteristics:
population based, prospective, longitudinal, and performed
in three stages (Fig. 1). In the first stage, clinical, nutritional,
and anthropometric evaluations, measurements of serum
and urinary markers for CKD, and examinations for comor-
bidities (systemic arterial hypertension [SAH], DM, CVD,
obesity, and dyslipidemia) were performed. The second
stage consisted of repeated examination of individuals with
CKD, SAH, and/or DM, image screening, and cardiac risk
assessment. The third stage included long-term monitoring
of all selected individuals.
Research team and study timeline
The PREVRENAL team is coordinated by two nephrologist
researchers and is composed of: two nephrologists, three
cardiologists, two imaging experts (one radiologist and one
vascular surgeon), two epidemiologists, four nurses, five
nutritionists, two social workers, four biochemists, nine
graduation students, and three drivers equipped with four-
wheel-drive vehicles. Trips for the first stage’s active search
were performed on non-holidayweekends, during a nine-
month period from August 2012 to April 2013. Image
experts did not participate during this stage. All researchers
were trained on the project’s basic procedures.
First stage
Data collection
A questionnaire was completed for each adult in each
household. Individual questionnaires were divided into
blocks with the following subjects: basic demographic
information (age, gender, marital status, and migration);
socioeconomic characteristics (education, occupation,
working relationship, and income); personal habits (smok-
ing, alcoholism, diet type, and physical exercises); clinical
data; arterial blood pressure(AP) status; previous disease
of the cardiovascular, renal, and respiratory systems; medi-
cations; and health services usage. A minor diet survey
was conducted in each family (including sodium content)
by nutritionists.
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Anthropometric measurements and arterial blood pressure
Weight was measured using an electronic scale with 150 kg
maximum capacity, and height was measured using a port-
able anthropometer with 0.1 cm accuracy. Measurements
were performed by two independent researchers. Individuals
were barefooted, wearing light clothes, and in the orthostatic
position. Body mass index(BMI) was calculated and classi-
fied according to the International Obesity Task Force
(IOTF) criteria. Waist circumference and reference values
for gender, age, and ethnicity were defined per NHANES III.
AP measurement was performed on the right arm of seated
individuals using a proper cuff, which covered 80% of the
distance between the olecranon and acromion. The pneu-
matic bag covered at least 40% of the arm circumference at
the level of the heart. Three measurements were performed
with a three-minute interval between them and after a five-
minute rest; then, the average of the last two measurements
was used. The oscillometric method was used for AP assess-
ment using a certified device.
Blood and urine collection
Blood was collected after a 12-h fast and the following
tests were performed: serum creatinine, urea, cystatin C,
glucose, calcium, phosphorus, albumin, cholesterol (total,
HDL, and LDL), triglycerides, serum iron, transferrin,
glutamic-pyruvic transaminase, ultrasensitive C-reactive
protein, and hemoglobin. Total blood and serum samples
were collected for freezer storage at − 80 °C. A genetic/
ethnic study and evaluations of inflammatory markers (IL-
6, TNFα) and APOL 1 polymorphism will be performed
using these samples.
Urine sample was collected by the individuals at home
and used for testing creatinine, albumin, abnormal
elements, and sediment. A second urine collection was
used for testing sodium excretion. Estimates for creatin-
ine excretion within 24 h (PrCr24h) and causal urine
sodium/creatinine ratio (NaUr) were obtained for esti-
mating the 24-h sodium excretion (Na24h) of isolated
samples, per Kawasaki’s Equation [14] (Kawasaki, 1993),
which was certified for the Brazilian population.
CKD diagnosis
CKD diagnosis was considered for those individuals pre-
senting with a GFR ≤60 mL/min/1.73m2 and/or albumin-
uria > 30 mg/day. The first parameter relates to functional
damageand the second indicates structural lesions of the
filtration barrier [15, 16] (KDIGO, 2013; LEVEY; BECKER;
INKER, 2015). For CKD diagnosis confirmation, GFR and
albuminuria tests were repeated three months after the first
test. GFR was estimated using four equations, of which
three are from the Chronic Kidney Disease - Epidemiologic
Collaboration Equation (CKD-EPI) study as follows: 1) one
equation based on creatinine values [17]; 2) one equation
based on cystatin C values; and 3) one equation based on
both creatinine and cystatin values [18]. Serum creatinine
was measured using the modified Jaffé’s method. Immuno-
turbidimetry was used to measurecystatin C.
Second stage
Cardiovascular risk
Cardiovascular risk assessment was performed using
Framingham’s risk score [19]. Arteriosclerosis was also
evaluated using two-dimensional ultrasonography of the
carotid arteries and computerized tomography of the
coronary arteries, in addition to tomographic measure-
ment of visceral fat.
Carotid artery two-dimensional ultrasonography Ca-
rotid intima-media thickness (CAIMT) was measured
using an ultrasonography device (Vivid3, Vingmed GE,
Horten, Norway). Examination was performed by a
single experienced blinded examiner, who was not aware
of the patient’s clinical and laboratory information, and
risk classification. Bilateral carotid system evaluation was
performed after at least 10 min of rest in the supine
position with the neck in slight hyperextension. CAIMT-
was measured at the artery wall of the common carotid,
Fig. 1 Flowchart of PREVRENAL study stages
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most distal to the transducer and 1 cm from the artery
bifurcation. Measurements consisted of the distance
between two echogenic lines traced at the lumen-intima
and media-adventitia interfaces, and were considered
normal when CAIMT< 0.9 mm, and abnormal when
CAIMT > 0.9 mm [20].
Abdominal computerized tomography (CT) Multi-
slice helical CT was performed using a 64-channel CT
scanner (Aquilion, Toshiba, Tokyo, Japan). First, a 10 mm
unique volumetric section is axially performed under apnea
(equivalent to 34 × 0.29-mm thick submillimeter cuts). A
tomographic section of the lumbar region at the navel level,
corresponding to the L3-L4 height, is usually topographic-
ally equivalent to the renal hilum projection (variation is
defined depending on each patient’s renal hilum height).
Examination was performed with a 0.4–0.6 s exposure time,
field of view corresponding to the sample’s frame size (be-
tween 320 and 440 m), and 120 kV energy potential at 340
mAs.
Visceral fat analysis was performed at the workstation,
using appropriate and specific software for the CT scanner,
capable of differentiating all abdominal structures con-
tained in the obtained volumetric section. Subsequently,
each section’s tridimensional reconstruction was obtained,
where all structures and organs are displayed through a
color scale that is subjectively standardized by the re-
searcher, facilitating tissue visualization, e.g. visceral fat.
After the reading and design stages, quantitative abdominal
visceral fat calculation is automatically performed by the
software and expressed as volume per mL. Section points
were defined as ≤102.5 cm3 (mL) for men and ≤84.1 cm3
(mL) for women [21].
Computerized tomographyof coronary arteries Im-
ages were obtained using the same equipment. Each
patient was placed in the supine position, and 3.0-mm
thick (on average) images were obtained without inter-
vals. Calcium presence was measured when the density
was above 130 Hounsfield units in at least three con-
tinuous pixels (>1mm2) of the same artery. The coronary
calcium score was composed of the sum of individual
scores from the left and right coronary arteries and was
analyzed and divided into categories according to the
methods ofMcCellandet al [22].
Cardiac and renal echo-Doppler All individuals with
reduced GFR, SAH, DM, and/or high albuminuria were
referred for echo-Doppler evaluation (Vivid3, Vingmed
GE, Horten, Norway), with second harmonic and sectorial
electronic transducer at 2–4 MHz. Cardiac and renal eval-
uations were performed. Cardiac evaluation consisted of
thoracic echo-Doppler cardiogram, in which the following
parameters were analyzed: ventricular geometry, systolic
function, and diastolic function, according to the Ameri-
can Society of Echocardiography (ASE) recommendations
[23, 24]. Renal evaluations consisted of obtaining the
intrarenal resistive index, using renal Doppler, according
to the methods ofRadermacher [25] (2002). In summary,
analysis was performed using pulsed wave Doppler,
obtaining the peak systolic (Vmax) and diastolic (Vmin)
velocities; the index was calculated using the following
equation: 100 x [1 - (Vmin/Vmax)]. The intrarenal resist-
ive index (IRI) was calculated as the average of measure-
ments performed for the upper, medium, and lower
segments of both kidneys.
Chronic kidney disease (CKD) confirmation
All individuals with reduced GFR, SAH, DM, and/or high
albuminuria were re-examined after three months in order
to confirm the diagnosis of CKD.
Third stage
All individuals selected for the first stage will be re-visited
and all examinations will be repeated five years after the
first stage.
Statistic analysis
First, a descriptive analysis of the variables under study
will be performed. Quantitative variables will be pre-
sented by mean and standard deviation and qualitative
variables by frequencies and percentages. The Shapiro
Wilk test will be used to evaluate the normality of the
quantitative variables.
For categorical variables, group comparison will be
based upon the results of the Chi-square test. Chi-square
test will be replaced by Fisher’s exact test if the expected
frequency in any of the cells of the contingency table is
less than 5. For continuous variables, group comparison
will be based upon the results of the t-test or the
Wilcoxon rank-sum test, depending on the normality.
In the primary analysis, the prevalence of CKD at baseline
and its corresponding 95% confidence interval (CI) will be
presented. Prevalence of hypertension, diabetes mellitus,
cardiovascular disease and other comorbidities at baseline
and their corresponding 95% CIs will also be presented.
In the secondary analysis, the factors associated with the
presence of CKD through bivariate analysis with an un-
adjusted prevalence ratio estimate and a 95% confidence
interval (95% CI) will be used. The independent variables
that present a significance lower than 0.20 (p-value < 0.20)
will be considered in the final model, that is, in the adjust-
ment of potentially confounding variables through the
multivariate logistic regression technique performed step
by step.
The comparison of survival (based on all-cause mor-
tality) between patients with and without CKD will also
be performed based upon the log-rank test performed at
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a significance level of 0.05. Hazard ratios and 95% CIs
will be calculated by a Cox proportional hazard regres-
sion model.
The data will be analyzed in the statistical program
STATA 12.0.
Ethical considerations
This study is being conducted in accordance with the prin-
ciples established by the 18th World Medical Assembly
(Helsinki, 1964) and all subsequent amendments.
The study was approved by the Research Ethics
Committee of the University Hospital of the Federal
University of Maranhão (n° 41,492/2012). Written
informed consent for participation in the study was
obtained from all participants.
Discussion
Brazil lacks early-stage CKD population study data. The
prevalence of CKD in our country is unknown for both
the overall and African descent populations. After iden-
tifying individuals with reduced GFR and high albumin-
uria, in an isolated population of African descendants,
this study proposes to monitor patients with or without
these conditions during long-term follow-up. This study
also seeks to identify other associated clinical conditions,
including SAH, DM, anemia, dyslipidemia, metabolic
syndrome, and cardiovascular risk. There are no specific
recommendations for detecting CKD in African descen-
dants [26, 27], thus four equations for estimating GFR
based on serum creatinine and cystatin were used and
will be compared.
To date, there are no reports on arteriosclerotic disease
and its relationship with GFR among Brazilian African
descendants. Data concerning clinical and laboratory
factors related to the development of arteriosclerosis
among individuals with impaired renal function during
pre-uremia stages and understanding of thisprocess’
development will allow the adoption of therapeutic and
preventive measures that enable reduction of cerebrovas-
cular and coronary events, which result in high morbidity
and mortality among this group of patients. Additionally,
our study is the first to quantify and evaluate factors asso-
ciated with coronary calcification in African descendants
who descend from African slaves and live in isolated
Brazilian communities, filling a gap of this research area.
Differences in CVD occurrence among ethnic groups
cannot be completely explained by traditional risk fac-
tors, even when taking into account the increased rate
ofSAH and DM among African descendants [28]. Thus,
the association between arteriosclerosis and CKD among
the various ethnic groups and impacts of risk factors on
this association are not well-established. Therefore, the
American Heart Association has recommended investi-
gations of arteriosclerotic CVD among all ethnic groups,
including long- and short-term risk analyses, in order to
fill this knowledge gap [29].
In addition to common ancestry, other factors contrib-
ute to the homogeneity of the studied population, e.g.
geographic and social isolation. Food habits of the studied
population are also similar and reveal the habit of con-
serving majority of perishable foods using salt, especially
meat, fish, and other seafood. Food sodium content was
evaluated through a food survey and quantified through
urinary sodium excretion tests. Local populations secure
subsistence by cultivating manioc (Manihotesculenta) for
flour production, hunting, fishing, and native fruits
extractivism, e.g. babaçu (Orbignyaphalerata), juçara
(Euterpeoleracea), and buriti (Mauritiaflexuosa L.). Socio-
economic status is equally low, a remarkable characteristic
of the majority of the population of the State of Maranhão,
which represents the lowest human development index
level and the lowest life expectancy in comparison with
other Brazilian states.
This study has some limitations. 1) It will be impossible
to properly monitor (every five years) the entire sample
(1539 individuals) due to difficulty of access to quilombo
communities. 2) A highly specific group will be moni-
tored; thus, results cannot be automatically extrapolated
to the entire Brazilian African decent population. 3)
Patients’ outcome will not follow a natural course, since
therapeutic interventions will occur as risk factors are
identified or diseases are diagnosed. 4) Finally, it is impos-
sible to reach the gold standard for urinary sodium excre-
tion quantification, due to difficulties in collecting urine
every 24 h.
In contrast, our study has the main positive aspect of
being the first study to quantify and evaluate factors
associated with kidney diseases in African populations
who descend from African slaves and live in isolated
Brazilian communities, providing missing information to
this area of research.
The PREVRENAL study describes characteristics of
the target population, selection of individuals, and detec-
tion of a population at risk, according to applied clinical
and laboratory evaluations. The methodology of imaging
examinations applied to the population at risk is also
described. The first and second stages were concluded
and results will be published in specific journals appro-
priate for each knowledge area. The subsequent stage is
the long-term and continuous monitoring of individuals
diagnosed with renal abnormalities, as well as those with
CKD risk factors, especially SAH and DM. The entire
sample will be re-evaluated five years after study initi-
ation. The expectation is to obtain information about
CKD evolution among this ethnic group, including
progression rate, development of complications (e.g.
anemia, mineral and bone disorder, acidosis, and uremia
symptoms), and occurrence of cardiovascular events,
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which has a high impact on morbidity and mortality of
CKD patients.
Therefore, we expect to contribute new information
about CKD development and progression within a spe-
cific population group that represents the base of the
Brazilian population. Results and reports of each topical
area will be sent to government branches responsible for
managing the national and local Unique Health System
(SUS - SistemaÚnico de Saúde), in order to assist the
establishment of public policies.
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